Pune: The Serum Institute of India (SII), which was conducting trials for the coronavirus vaccine being developed by Oxford University in the country, has stopped clinical trials of the vaccine.
“We are reviewing the situation and pausing India trials till @AstraZeneca restarts them,” it tweeted.
The phase 3 clinical study of the COVID-19 vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca had to be halted after a volunteer developed ‘an unexplained illness’.
On Tuesday, AstraZeneca said that it had paused late-stage trials to allow an independent committee to review safety data.
Also Read: Oxford-AstraZeneca Vaccine Put On Hold After Volunteer Develops Unexplained Illness
The following day, SII CEO Adar Poonawalla said that this incident in the UK will have no impact on the Indian vaccine trial being carried out by the institute. “Nothing untoward has been reported during the vaccine trials in India,” he said
The institute, however, decided to halt the trials after the drug regulator issued a show-cause notice following the adverse results in the UK clinical trials.
Also Read: COVID Vaccine: Oxford Pause Won’t Impact Trials In India
Mumbai: The first poster of the Tiger Shroff-starrer ‘Baaghi 4’ is out. The poster shows…
Bhubaneswar: What came first -- chicken or egg? Scientists have finally found some evidence to…
Mumbai: Ashneer Grover of Shark Tank India fame, who was slammed by Salman Khan on…
New Delhi: Prime Minister Narendra Modi met outgoing US President Joe Biden and other world…
Balasore: A POCSO Court has sentenced a man to rigorous imprisonment for 25 years for…
Bhubaneswar: An elderly man from West Bengal was found hanging in the room of a…
Bhubaneswar: Three players from Odisha have been selected for the Indian team which will compete…
Ranchi: Five days after the Supreme Court laid down nationwide guidelines against arbitrary demolitions by…